InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Michael Häggman, Director. Director active across 1 company, notably Prostatype Genomics AB. Cumulatively, 3 reports have been recorded. History available since 5 June 2025. The latest transaction was filed on 5 August 2026 (Purchase). Regulator: FIN-FSA. The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Michael Häggman is a Board Member of Prostatype Genomics AB. In this role, he participates in strategic decisions and oversees the company's operations. Michael brings his expertise and experience to support management in achieving Prostatype's objectives. His commitment to good governance is essential for the company's success.